Gastrostomy Feeding Tube (G-tube) Market Size, Share, Growth, and Industry Analysis, By Type (High Profile G-tube,Low Profile G-tube,Other), By Application (Children,Adult), Regional Insights and Forecast to 2035

Gastrostomy Feeding Tube (G-tube) Market Overview

The global Gastrostomy Feeding Tube (G-tube) Market size is projected to grow from USD 1189.74 million in 2026 to USD 1269.7 million in 2027, reaching USD 2135.99 million by 2035, expanding at a CAGR of 6.72% during the forecast period.

The Gastrostomy Feeding Tube (G-tube) Market serves enteral nutrition via percutaneous endoscopic gastrostomy (PEG), radiologically inserted gastrostomy (RIG), and surgical techniques; annually an estimated 100,000–200,000 PEG procedures are performed in the United States and roughly 90,000 gastrostomy placements were reported in sample healthcare datasets over specific multi-year windows, driving device demand. Low-profile (button) and high-profile tube formats represent major product classes, with low-profile options increasingly chosen for pediatric and homecare settings; product segmentation shows high-profile units remain common in acute hospital deployments with tens of thousands of in-hospital insertions per year in major markets, forming the core of any Gastrostomy Feeding Tube (G-tube) Market Analysis and Gastrostomy Feeding Tube (G-tube) Market Report.

In the United States, percutaneous endoscopic gastrostomy accounts for the majority of gastrostomy access, with documented annual procedural volumes between 100,000 and 200,000 PEG placements; pediatric PEG insertions number in the low thousands annually, while adult and geriatric cohorts account for the remainder. U.S. hospitals typically stock a mix of 3–7 commercial G-tube models per surgical or endoscopy unit, and homecare providers manage average dispensation of 10–20 replacement devices per long-term patient per year. These utilization and stocking metrics are central inputs for a Gastrostomy Feeding Tube (G-tube) Market Research Report and Gastrostomy Feeding Tube (G-tube) Market Forecast used by manufacturers and distributors.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Growing global prevalence of chronic diseases such as stroke, cancer, and neurological disorders has led to more than 200,000 new gastrostomy tube placements annually across major healthcare markets.
• Major Market Restraint: High complication rates, averaging 2–15% across reported PEG procedures, and inconsistent insurance coverage have limited uniform adoption across outpatient and homecare environments.
• Emerging Trends: Over 80 new low-profile G-tube product models were launched globally between 2023 and 2025, and more than 30 telehealth pilot programs integrated remote G-tube monitoring systems into patient care.
• Regional Leadership: North America leads with around 100,000–200,000 annual G-tube procedures, followed by Europe with 60,000–80,000 and Asia-Pacific exceeding 50,000 new placements per year.
• Competitive Landscape: The top four manufacturers collectively supply over 70% of hospital and homecare G-tube inventories, with a combined global distribution covering more than 100 countries.
• Market Segmentation: Low-profile devices dominate outpatient use, accounting for 9 out of every 10 pediatric and homecare conversions, while high-profile devices remain prevalent in acute-care hospitals.
• Recent Development: Between 2023 and 2025, manufacturers launched over 15 new G-tube product lines, introduced 10 new pediatric variants, and completed more than 20 clinical performance evaluations worldwide.

Gastrostomy Feeding Tube (G-tube) Market Latest Trends

Recent Gastrostomy Feeding Tube (G-tube) Market Trends show growing use of low-profile devices, homecare management programs, and enteral formula integration that link device and nutrition offers; low-profile (button) tubes accounted for a plurality of outpatient conversions, with thousands of hospital-to-home transitions recorded yearly and sample market analyses reporting tens of thousands of button conversions across major markets between 2022 and 2024. Pediatric demand remains significant: pediatric G-tube placements continue in the thousands annually in high-income countries, and neonatal intensive care units reported several hundred new long-term enteral access starts per year in multi-center studies.

Gastrostomy Feeding Tube (G-tube) Market Dynamics

DRIVER

"Aging population and chronic disease prevalence"

The principal driver of Gastrostomy Feeding Tube (G-tube) Market Growth is demographic aging and rising chronic diseases requiring long-term enteral nutrition: in developed markets, populations aged 65+ surpass 15–20% of total residents, and chronic dysphagia, stroke sequelae, neurodegenerative disorders, and oncology make up the majority of indications for gastrostomy access, contributing to tens of thousands of new G-tube placements annually. Homecare and long-term care facilities accounted for thousands of maintenance procedures and device exchanges per year in national datasets, while hospitals reported average in-hospital dwell times for newly inserted G-tubes ranging from 3 to 7 days before discharge planning. As a result, device manufacturers and distributors include these utilization baselines in every Gastrostomy Feeding Tube (G-tube) Market Analysis and Gastrostomy Feeding Tube (G-tube) Market Size assessment.

RESTRAINT

"Procedure risk perceptions and reimbursement complexity"

Adoption is restrained by procedural risk perceptions and reimbursement variability: percutaneous endoscopic gastrostomy (PEG) carries procedural risks—reported complication rates range from 2% to 15% depending on cohort and definitions—leading some clinicians and families to delay placement. Insurance and payer policies differ widely: in some systems preauthorization and documentation necessitate 4–8 weeks of care coordination before approval for outpatient tube placement and supplies, reducing timely access. Device pricing for accessories and replacement sets influences payer reviews, often requiring detailed itemization with 5–10 supporting clinical notes per long-term patient. These factors are frequently cited in Gastrostomy Feeding Tube (G-tube) Industry Reports as adoption barriers.

OPPORTUNITY

"Homecare bundles, low-profile innovation, and training programs"

Opportunities in the Gastrostomy Feeding Tube (G-tube) Market include integrated homecare bundles, new low-profile device designs, and enhanced clinician/caregiver training: bundled supply programs can provide 12–24 months of consumables per contract, reducing unit costs for payers and improving adherence. Low-profile devices increasingly feature magnetless coupling and anti-reflux valves; more than 10 new product variants were trialed across pediatric and adult cohorts in 2023–2025. Training programs and nurse-led outpatient clinics have reduced emergency replacement visits by up to 30% in program pilots, and telehealth follow-up schedules averaging 2–4 remote checkups in the first month post-insertion improved complication detection. These opportunities are central to Gastrostomy Feeding Tube (G-tube) Market Opportunities and Gastrostomy Feeding Tube (G-tube) Market Insights for B2B providers.

CHALLENGE

"Infection control and supply chain constraints"

Key challenges include infection prevention and supply chain resilience: peristomal infection rates in cohort studies vary from 5% to 20%, necessitating protocols that add consumable usage and training; central supply shortages occurred episodically in 2022–2024, with some distributors reporting backorders on specific Luer connectors and extension sets for 2–6 weeks. Pediatric-sized interfaces and specialized button sizes require distinct SKUs—manufacturers typically maintain 6–12 size SKUs per product line—making inventory management complex for smaller providers. These operational and clinical challenges are examined in depth in Gastrostomy Feeding Tube (G-tube) Market Research Reports and Gastrostomy Feeding Tube (G-tube) Industry Analysis.

Gastrostomy Feeding Tube (G-tube) Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

The Gastrostomy Feeding Tube (G-tube) Market segments by type—High-Profile G-tube, Low-Profile G-tube, Other—and by application—Children and Adult. High-profile tubes account for the majority of acute hospital insertions, while low-profile devices dominate outpatient and pediatric use; sample procurement datasets show low-profile conversions numbering in the tens of thousands across major markets between 2022 and 2024.

BY TYPE 

High-Profile G-tube: High-profile gastrostomy tubes (also called standard tubes) remain widely used for inpatient and short-term feeding indications; hospitals report stocking 2–5 sizes for immediate post-procedure use. High-profile devices are used in initial PEG placements and for interventional radiology (IR)–guided insertions, and annually tens of thousands of high-profile tubes are placed in acute care settings across major health systems.

The High Profile G-tube segment is valued at USD 563.21 million in 2025, projected to reach USD 1012.78 million by 2034, with a CAGR of 6.80%, supported by rising adoption in hospitals and specialized care centers.

Top 5 Major Dominant Countries in the High Profile G-tube Segment:

• United States: Holds USD 210.45 million in 2025, expected to reach USD 378.12 million by 2034, growing at 6.82% CAGR, fueled by advanced healthcare infrastructure and enteral nutrition adoption.
• Germany: Estimated at USD 78.34 million in 2025, projected to USD 140.23 million by 2034, with 6.79% CAGR, driven by chronic disease management and pediatric care applications.
• Japan: Accounts for USD 63.12 million in 2025, expected to reach USD 112.56 million by 2034, at 6.81% CAGR, supported by geriatric patient population and clinical adoption.
• France: Registers USD 48.56 million in 2025, projected to USD 86.78 million by 2034, growing at 6.80% CAGR, driven by hospitals and specialized nutrition centers.
• United Kingdom: Holds USD 36.78 million in 2025, expected to reach USD 65.45 million by 2034, at 6.77% CAGR, fueled by increasing awareness and supportive reimbursement policies.

Low-Profile G-tube: Low-profile (button) gastrostomy tubes are increasingly common in homecare and pediatric populations, with tens of thousands of outpatient conversions reported in recent years; low-profile devices provide a discreet external profile of <10 mm height and often come in multiple internal flange diameters (e.g., 12–24 Fr) to match patient stoma sizes. Button devices typically require replacement every 3–12 months depending on material and use, driving recurring consumable demand for access ports, extension sets and skin barriers with average monthly consumable orders of 4–10 items per patient.

The Low Profile G-tube segment is valued at USD 471.23 million in 2025, expected to achieve USD 845.12 million by 2034, exhibiting a CAGR of 6.65%, driven by pediatric use and outpatient care preference.

Top 5 Major Dominant Countries in the Low Profile G-tube Segment:

• United States: Estimated at USD 178.12 million in 2025, projected to USD 319.45 million by 2034, at 6.68% CAGR, fueled by pediatric and long-term care adoption.
• Germany: Holds USD 65.34 million in 2025, expected to reach USD 117.78 million by 2034, growing at 6.64% CAGR, driven by outpatient nutrition programs.
• Japan: Registers USD 59.12 million in 2025, projected to USD 105.23 million by 2034, at 6.66% CAGR, supported by homecare nutrition trends.
• France: Accounts for USD 41.45 million in 2025, projected to USD 73.45 million by 2034, at 6.65% CAGR, fueled by clinical adoption.
• United Kingdom: Estimated at USD 34.23 million in 2025, expected to reach USD 60.12 million by 2034, at 6.63% CAGR, supported by hospital and outpatient usage.

Other: Other gastrostomy access devices include jejunostomy extensions, specialized anti-reflux G-tubes, and balloon-retained PEG variants; collectively these represent a modest but clinically important share of placements—thousands of specialized devices are used annually in cases requiring post-pyloric feeding or combined decompression and nutrition.

The Other segment is valued at USD 80.38 million in 2025, projected to reach USD 143.59 million by 2034, growing at a CAGR of 6.70%, driven by specialty tubes and niche clinical applications.

Top 5 Major Dominant Countries in the Other Segment:

• United States: Holds USD 35.12 million in 2025, expected to USD 62.45 million by 2034, at 6.72% CAGR, driven by specialized clinical care.
• Germany: Estimated at USD 14.23 million in 2025, projected to USD 25.45 million by 2034, at 6.70% CAGR, supported by niche hospital applications.
• Japan: Registers USD 11.45 million in 2025, expected to USD 20.78 million by 2034, growing at 6.71% CAGR, fueled by geriatric and homecare adoption.
• France: Accounts for USD 10.12 million in 2025, projected to USD 18.45 million by 2034, at 6.69% CAGR, supported by outpatient care.
• United Kingdom: Estimated at USD 9.45 million in 2025, reaching USD 17.45 million by 2034, at 6.68% CAGR, driven by specialized nutrition programs.

BY APPLICATION

Children: Pediatric gastrostomy use includes neonates, infants and older children with congenital or acquired feeding disorders; pediatric placements number in the low thousands annually in major healthcare markets and pediatric discharge data indicate average in-hospital stays around 3–7 days for uncomplicated PEG insertions in children. Pediatric G-tube patients often require smaller French sizes (e.g., 12–18 Fr) and specialized accessories; clinic schedules typically include 3–4 follow-ups in the first month post-placement.

The Children application segment is valued at USD 452.12 million in 2025, projected to reach USD 810.78 million by 2034, growing at a CAGR of 6.70%, driven by pediatric feeding disorders and homecare adoption.

Top 5 Major Dominant Countries in Children Application:

• United States: Holds USD 178.45 million in 2025, projected to USD 319.12 million by 2034, at 6.72% CAGR, fueled by pediatric hospitals and homecare facilities.
• Germany: Estimated at USD 64.12 million in 2025, reaching USD 115.23 million by 2034, at 6.69% CAGR, supported by pediatric care programs.
• Japan: Registers USD 57.23 million in 2025, expected to USD 103.12 million by 2034, at 6.71% CAGR, driven by clinical and homecare adoption.
• France: Accounts for USD 42.12 million in 2025, projected to USD 76.45 million by 2034, at 6.70% CAGR, supported by pediatric nutrition initiatives.
• United Kingdom: Estimated at USD 36.12 million in 2025, reaching USD 65.78 million by 2034, at 6.68% CAGR, fueled by hospitals and outpatient programs.

Adult: Adult and geriatric applications dominate overall device volumes, with the plurality of PEG placements occurring in stroke, head and neck cancer, and progressive neurological disease cohorts; adult placements number in the tens to hundreds of thousands across combined markets annually. Adult tube sizes range commonly from 14–24 Fr and retention balloons for replacement devices typically use 5–15 mL of sterile water.

The Adult application segment is valued at USD 662.70 million in 2025, expected to reach USD 1,190.71 million by 2034, growing at a CAGR of 6.73%, driven by chronic diseases and geriatric nutrition needs.

Top 5 Major Dominant Countries in Adult Application:

• United States: Holds USD 235.12 million in 2025, projected to USD 422.45 million by 2034, at 6.74% CAGR, driven by hospitals and homecare services.
• Germany: Estimated at USD 93.45 million in 2025, reaching USD 167.78 million by 2034, at 6.72% CAGR, supported by adult nutrition programs.
• Japan: Registers USD 69.12 million in 2025, projected to USD 123.45 million by 2034, at 6.73% CAGR, fueled by geriatric and chronic disease care.
• France: Accounts for USD 57.23 million in 2025, projected to USD 102.12 million by 2034, at 6.72% CAGR, supported by hospital and outpatient adoption.
• United Kingdom: Estimated at USD 45.23 million in 2025, reaching USD 80.78 million by 2034, at 6.71% CAGR, driven by adult nutrition and care facilities.

Gastrostomy Feeding Tube (G-tube) Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Regional performance in the Gastrostomy Feeding Tube (G-tube) Market concentrates in North America, Europe and Asia-Pacific; North America leads procedural volumes with tens of thousands of annual PEG placements, Europe and APAC follow with high procedural counts in major tertiary centers, and MEA and Latin America show growing but smaller adoption with pilot programs and expanding homecare capacity, shaping the Gastrostomy Feeding Tube (G-tube) Market Outlook and Gastrostomy Feeding Tube (G-tube) Market Opportunities.

NORTH AMERICA

North America is the largest region for the Gastrostomy Feeding Tube (G-tube) Market, with the United States performing between 100,000 and 200,000 PEG procedures annually across hospitals and outpatient endoscopy centers. 

The North America Gastrostomy Feeding Tube (G-tube) Market is valued at USD 452.34 million in 2025, projected to reach USD 815.12 million by 2034, growing at a CAGR of 6.71%, driven by advanced healthcare infrastructure and rising enteral nutrition adoption.

North America - Major Dominant Countries:

• United States: Holds USD 410.12 million in 2025, projected to USD 739.45 million by 2034, at 6.72% CAGR, fueled by hospital adoption and homecare nutrition.
• Canada: Estimated at USD 32.12 million in 2025, projected to USD 58.12 million by 2034, at 6.69% CAGR, supported by growing clinical awareness.
• Mexico: Registers USD 5.23 million in 2025, projected to USD 9.78 million by 2034, at 6.68% CAGR, driven by healthcare infrastructure expansion.
• Puerto Rico: Accounts for USD 3.12 million in 2025, projected to USD 5.78 million by 2034, at 6.67% CAGR, supported by hospital programs.
• Greenland: Estimated at USD 1.77 million in 2025, expected to reach USD 3.12 million by 2034, at 6.66% CAGR, fueled by outpatient adoption.

EUROPE

Europe hosts a large base of gastrostomy procedures with major activity in countries such as Germany, the United Kingdom, France, and the Nordics; national registries report thousands of PEG insertions per year per large nation, and regional networks maintain device standardization committees that evaluate 5–10 device classes annually. 

The Europe Gastrostomy Feeding Tube (G-tube) Market is valued at USD 352.78 million in 2025, expected to grow to USD 632.12 million by 2034, at a CAGR of 6.70%, supported by rising chronic diseases and clinical adoption.

Europe - Major Dominant Countries:

• Germany: Leads with USD 120.12 million in 2025, projected to USD 215.12 million by 2034, at 6.71% CAGR, driven by hospital and outpatient usage.
• France: Holds USD 85.12 million in 2025, projected to USD 152.12 million by 2034, at 6.70% CAGR, supported by geriatric nutrition programs.
• United Kingdom: Accounts for USD 65.12 million in 2025, expected to USD 116.12 million by 2034, at 6.69% CAGR, fueled by hospital adoption.
• Italy: Registers USD 50.12 million in 2025, projected to USD 89.12 million by 2034, at 6.68% CAGR, driven by clinical programs.
• Spain: Estimated at USD 32.12 million in 2025, expected to USD 57.12 million by 2034, at 6.67% CAGR, supported by healthcare expansion.

ASIA-PACIFIC

Asia-Pacific is an expanding Gastrostomy Feeding Tube (G-tube) Market region with large procedural volumes in China, Japan, South Korea and Australia; combined annual PEG placements in the region number in the tens of thousands, with China and Japan representing the majority. OSH and tertiary hospitals in APAC commonly maintain stock levels supporting 50–200 monthly tube exchanges per large facility. 

The Asia Gastrostomy Feeding Tube (G-tube) Market is valued at USD 212.45 million in 2025, projected to reach USD 378.78 million by 2034, at a CAGR of 6.74%, driven by increasing hospital penetration and pediatric care adoption.

Asia - Major Dominant Countries:

• Japan: Holds USD 78.12 million in 2025, projected to USD 140.12 million by 2034, at 6.73% CAGR, fueled by pediatric and geriatric nutrition programs.
• China: Estimated at USD 65.12 million in 2025, projected to USD 116.12 million by 2034, at 6.74% CAGR, driven by hospital and homecare adoption.
• India: Registers USD 32.12 million in 2025, expected to USD 57.78 million by 2034, at 6.72% CAGR, supported by clinical nutrition programs.
• South Korea: Accounts for USD 22.12 million in 2025, projected to USD 39.12 million by 2034, at 6.71% CAGR, fueled by hospital usage.
• Australia: Estimated at USD 15.12 million in 2025, expected to USD 27.78 million by 2034, at 6.70% CAGR, driven by outpatient adoption.

MIDDLE EAST & AFRICA

Middle East & Africa currently represent a smaller but developing share of the Gastrostomy Feeding Tube (G-tube) Market, with early adoption concentrated in tertiary hospitals and government medical centers; combined region procedural counts number in the low thousands annually. Facilities in the Gulf Cooperation Council (GCC) countries have begun stocking low-profile and high-profile devices in central hospitals, often maintaining 1–3 supplier partnerships for device and consumable coverage.

The Middle East and Africa Gastrostomy Feeding Tube (G-tube) Market is valued at USD 97.35 million in 2025, projected to reach USD 177.49 million by 2034, at a CAGR of 6.70%, driven by growing hospital infrastructure and chronic disease management.

Middle East and Africa - Major Dominant Countries:

• Saudi Arabia: Holds USD 32.12 million in 2025, projected to USD 58.12 million by 2034, at 6.71% CAGR, supported by hospital nutrition programs.
• United Arab Emirates: Estimated at USD 22.12 million in 2025, projected to USD 40.12 million by 2034, at 6.70% CAGR, driven by clinical adoption.
• South Africa: Registers USD 15.12 million in 2025, projected to USD 27.78 million by 2034, at 6.69% CAGR, fueled by pediatric and adult nutrition demand.
• Egypt: Accounts for USD 12.12 million in 2025, projected to USD 22.12 million by 2034, at 6.68% CAGR, supported by hospitals and outpatient care.
• Israel: Estimated at USD 16.12 million in 2025, reaching USD 29.12 million by 2034, at 6.70% CAGR, driven by clinical and homecare adoption.

List of Top Gastrostomy Feeding Tube (G-tube) Companies

• Boston Scientific
• ConMed
• Applied Medical Technology
• GBUK Group
• Cardinal Health
• Cook Group
• Danone
• Avanos Medical
• Fresenius Kabi
• Nestle

Fresenius Kabi: Identified by industry analyses as one of the top two companies with leading global presence, Fresenius Kabi supplies enteral nutrition and integrated gastrostomy system offerings with distribution into >100 countries and robust hospital procurement programs.

Cardinal Health: Recognized as a top two company with extensive distribution and medical supply channels, Cardinal Health supports thousands of hospital customers and homecare providers, with product lines and supply networks covering >80 national markets.

Investment Analysis and Opportunities

Investment in the Gastrostomy Feeding Tube (G-tube) Market targets device innovation, homecare logistics, and consumable service models; between 2022 and 2024 multiple suppliers expanded manufacturing capacity with capital allocations averaging 10–20% of incremental production budgets to increase tube and accessory output by tens of thousands of units annually. Private equity and strategic investors evaluated bundled care programs offering 12–24 month supply contracts and in some markets purchased distribution platforms serving >1,000 homecare patients. 

New Product Development

New product development in the Gastrostomy Feeding Tube (G-tube) Market from 2022–2025 emphasized smaller profile buttons, anti-reflux valves, integrated skin barriers, and more durable materials reducing replacement frequency to every 3–12 months depending on SKU. Over 15 product variants targeting pediatric ergonomics and adult comfort were introduced and tested in multi-center usability studies involving 100–1,000 patients per trial. 

Five Recent Developments

• Multiple suppliers expanded manufacturing lines to increase G-tube output by 20–30%, adding tens of thousands of device units capacity in 2024.
• Over 10 pilot programs introduced fluxless anti-reflux low-profile buttons with integrated skin barriers across pediatric clinics in 2023–2025.
• Homecare distributors launched bundled subscription programs covering 12 months of consumables for G-tube patients in pilot regions, enrolling >1,000 patients in initial phases.
• Telehealth aftercare pilots with 2–4 remote checkups in the first month post-insertion reduced emergency replacements by up to 30% in participating hospitals.
• A leading supplier standardized 6–8 SKU sizes for pediatric buttons to streamline inventory management, reducing stockouts by recorded single-digit percentages in test regions.

Report Coverage of Gastrostomy Feeding Tube (G-tube) Market

This Gastrostomy Feeding Tube (G-tube) Market Research Report covers device segmentation (High-Profile G-tube, Low-Profile G-tube, Others), application splits (Children and Adult), regional footprints, clinical utilization metrics, procurement patterns, and buyer segmentation (hospitals, homecare agencies, long-term care facilities). It compiles procedural baselines—such as 100,000–200,000 annual PEG placements in the U.S. and thousands more across Europe and Asia—SKU inventories per facility (3–7 models), expected consumable orders per patient (4–12 per month), and device replacement intervals (3–12 months). 

Gastrostomy Feeding Tube (G-tube) Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1189.74 Million in 2026
Market Size Value By	USD 2135.99 Million by 2035
Growth Rate	CAGR of 6.72% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : High Profile G-tube Low Profile G-tube Other By Application : Children Adult
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample